Yuanqiang Jiang

Effect of low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor priming (CAG regimen) on the outcome of elderly patients with acute myeloid leukemia

Sixuan Qian, Jianyong Li, Tian Tian et al. · Leukemia Research · 2007 · 43 citations

Medicine, Oncology, Pharmacology +13

HIF-α Promotes Chronic Myelogenous Leukemia Cell Proliferation by Upregulating p21 Expression

Chen Heng, Yunfeng Shen, Fang Gong et al. · Cell Biochemistry and Biophysics · 2015 · 29 citations

Medicine, Cancer Biology, Oncology +9

Coagulation profiles and thromboembolic events of bortezomib plus thalidomide and dexamethasone therapy in newly diagnosed multiple myeloma

Yunfeng Shen, Xin Zhou, Zhi Wang et al. · Leukemia Research · 2010 · 19 citations

Medicine, Hematology, Oncology +17

Bortezomib plus intermediate‐dose dexamethasone and thalidomide in elderly untreated patients with multiple myeloma: A Chinese experience

Hongfeng Guo, Xin Zhou, Yuanqiang Jiang et al. · American Journal of Hematology · 2010 · 13 citations

Pharmacy, Pharmacology, Pharmacotherapy +13

JAK2 V617F, MPL W515L and JAK2 exon 12 mutations in Chinese patients with primary myelofibrosis

Jun Xia, Mize Lu, Yuanqiang Jiang et al. · Chinese Journal of Cancer Research · 2012 · 10 citations · Full text

Medicine, Genetics, Hematology +12